I thought this was worth sharing. From Dante on

New Post Public Reply Private Reply Replies (0) Message Board
Buddyboy20
754
I thought this was worth sharing. From Dante on YMB:

dante

"Apologizes to longs my hypothesis on the call was wrong. I’ve never seen a company do a market hours CC without significant market moving news especially in December (partner and buy out season).…. I have to stay 100% truthful to longs. I thought the call wasn’t needed and had little to no new information. Even the “new hires” they talked about that on previous calls. I think the biggest problem we have is “perception” there are biotechs in phase 1 with 2 indications for cancer their on nasdaq and stock prices are 15+ Dollars. Even the arena 100$ buy out from Pfizer. They have 2 drugs in phase 3……….all their pipeline combined doesn’t equal LERONLIMAB’S indications and market potential. We have a phase 3 trial that hit stat sig as well. They don’t.
The problem we face is when someone mentions Cydy they don’t think about this life saving molecule. The public perception is “oh that’s the company with all that noise and controversy” a lot of it forced and tactically put upon us by the dark powers that try to see us destroyed. But I believe the management can minimize this be more stealth coming into 2022.
First. Stop addressing “shorts” most are run by bots anyways that use a sentence generator algo with a timer to release comments at different times throughout the day. Second. If you want “shorts” to not bash data put out detailed PR’s that make sense and clarify everything to a TEE. I think it would also be great if every PR had a Column “Dr.Recknors data analysis” where he breaks the data down and gives his opinions. People want to hear what he has to say. It should be him in every PR. Then no one will be able to “bash the data”
third. People are being desensitized to NEWS. Why release the 5 patients of NASH data just release the whole study when it’s ready with a top line report for MAX impact. If data needs to be explained please put dr. Recknor on a proactive so he can do it. In future CC’s I think it would be nice we hear from the cydy biomarkers lab teammates. 2022 is the biggest year of the companies history. There needs to be changes on the public perception of the company a lot of it is out of the companies hands but they can also help themselves minimize it.

Nadar you should put this Quote on your office wall.
“Let your plans be dark and impenetrable as night, and when you move, fall like a thunderbolt.”
Sun Tzu, The Art of War

GODSPEED."

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Activewear Faces Major Class Action Lawsuit

Updated Category News Views 85

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 158

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading
ROKAE Hits 10,000 Delivery Mark for Robotic Arms

Updated Category News Views 148

ROKAE's Big 10K: A Milestone Worth Noting Alright, if you've been around the block as long as I have, you know the robotics game isn't just about making cool gadgets—it's about hitting those serious deployment numbers. ROKAE Robotics just rolled its 10,000th humanoid force-controlled arm off the line in Shandong, and this ain't just another notch on their belt. This...

Continue Reading
Metallium's U.S. Supply Chain Ambitions Hinge on Traxys MOU

Updated Category News Views 79

Metallium and Traxys Partner to Boost U.S. Critical Metals Out there in Houston, October's cooked up a potential game-changer for U.S. critical metals supply like no one's business. Metallium Limited—those savvy cats juggling ASX and OTC markets—just laid down a non-binding Memorandum of Understanding (MOU) with Traxys North America LLC. The goal? To sharpen up and...

Continue Reading
Bank of America Faces Legal Battle Over Compliance Failures

Updated Category News Views 39

Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...

Continue Reading
Duke Energy's Battle Against Energy Vampires Heats Up

Updated Category News Views 84

Unplugging Hidden Electricity Drains Ever wonder why your electric bill has been sneakily creeping up? You might think it's just the AC running full blast or lights left on, but surprise, surprise—there’s a whole army of “energy vampires” quietly sucking the juice out of your home. Duke Energy Florida is drawing attention to this sneaky leak, especially around...

Continue Reading
WuXi AppTec Boosts Guidance Amid Strong CRDMO Growth

Updated Category News Views 158

Unpacking WuXi AppTec's Latest Performance Boost WuXi AppTec, the pharmaceutical giant, isn't just coasting on its past successes. The way they're riding the contract research, development, and manufacturing (CRDMO) train straight through Q1 to Q3 of 2026 shows they're not just here for show. They've hiked up the stakes with strong metrics across the board, warranting a...

Continue Reading
University of Phoenix Grads Gain High Praise from Managers

Updated Category News Views 0

Forget the stereotypes that tag University of Phoenix as just another factory for diplomas. The latest survey results paint a picture of graduates who seem to be real go-getters in the workplace. We’ve got managers from all over singing the praises of these alums, with a whopping 96% ready to vouch for them stepping into bigger roles. Not just talk, folks, this is their...

Continue Reading
Shenzhen Hosts FDI Moot: A Key Milestone for Arbitration

Updated Category News Views 93

Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...

Continue Reading
Kevin Burke Strengthens Latham's Private Equity Team

Updated Category News Views 0

Big Moves in the Legal Arena Holy guacamole, folks—Kevin Burke just landed a plum spot at Latham & Watkins, stepping into their Mergers & Acquisitions and Private Equity team in New York. You might ask, who cares? Well, savvy investors and PE players should pay attention because moving legal minds like Burke can stir up the whole private equity scene. Who's This Burke...

Continue Reading

Top 5 Most Recently Viewed Articles

Allegion Launches New Schlage Performance Series Locks for Businesses

Updated Category News Views 200

Allegion Expands Offerings with Performance Series Locks Allegion, a renowned name in security solutions, has just unveiled the Schlage Performance Series Locks, a new suite designed specifically for commercial spaces. These locks provide the perfect blend of style, security, and functionality, catering to the diverse needs of modern businesses. Innovative Solutions for...

Continue Reading
AM Best Upholds Strong Ratings for Transmonde Services Insurance

Updated Category News Views 92

AM Best Confirms Credit Ratings for Transmonde Services Insurance Company AM Best has recently affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of "a" (Excellent) for Transmonde Services Insurance Company Limited. This affirmation highlights the company's solid financial standing and acknowledges its stable outlook in the...

Continue Reading
Exploring the Growth of Marathon Petroleum Investments

Updated Category News Views 206

How Marathon Petroleum Has Surged in Value Over the past decade, Marathon Petroleum (MPC) has shown impressive performance, outperforming the market by an annualized rate of 1.07%, yielding an average annual return of 14.15%. Currently, the company's market capitalization stands at an impressive $49.97 billion, reflecting its strong position in the marketplace. The Impact...

Continue Reading
Insights on Women's Birth Control Experiences and Preferences

Updated Category News Views 349

Women’s Experiences with Birth Control and Side Effects Recent findings shed light on the experiences of women using various birth control methods. A survey conducted involving over 450 women aged 18 to 70 highlighted some compelling results regarding the use of contraceptives. While a majority reported satisfaction with their current methods, a notable portion, nearly...

Continue Reading
Wealthcare's Growth and New Partnership Exceed $9 Billion AUM

Updated Category News Views 145

Wealthcare Secures A New Financial Partnership Wealthcare Capital Management, a pioneering technology-enabled Registered Investment Advisor (RIA), has made remarkable strides in the first half of 2025. The firm has established a partnership with Sammons Financial Group, reinforcing its commitment to enhance the support provided to independent financial advisors. This...

Continue Reading